Statins.

Not a drug in isolation.

If you've read The Invisible Fire, you have the frame you need. Most modern chronic disease — type 2 diabetes, fatty liver, high blood pressure, much of heart disease — shares one root: insulin resistance, the slow metabolic fire. Each condition is that fire surfacing somewhere, and each gets its own specialist, its own number, and its own drug.

Statins are the drug for one of those numbers: cholesterol. So the honest way to understand them isn't to argue about cholesterol in isolation — it's to see where the statin sits in the fire.

You'll be told the condition is "high cholesterol." But a number on a blood test is not a disease. Nobody dies of a number — what people suffer is a heart attack or a stroke. So the real thing anyone cares about is cardiovascular risk, and cholesterol is only one rough input into it.

Now go one step further, using what the Invisible Fire showed. Ask why the cholesterol is high. For most people it isn't the butter or the eggs — it's the fire. High insulin, through a liver switch called SREBP, turns on the very machinery that makes cholesterol.[1] So a raised cholesterol number is often not the disease at all:

It's frequently a sign that insulin is running high and the metabolic fire is burning — which reframes the whole question. It was never "is your number high?" It's "what is driving it, and what is your real risk?" A statin answers neither. It simply forces the number down.

The strongest opposing point, conceded.

If you've already had a heart attack or stroke, or have established heart disease, statins genuinely reduce your chance of dying. This is secondary prevention, and here the evidence is strong, consistent, and about a hard outcome — death — not just a number.

The landmark trial is the Scandinavian Simvastatin Survival Study ("4S"): 4,444 people who already had heart disease, followed 5.4 years.[2] Both numbers, side by side, as this series always insists:

Real and worth having: treating 100 such high-risk people for six years prevents roughly four deaths and seven non-fatal heart attacks, with no excess deaths from other causes. For someone who's already had a heart attack, this is genuine, life-saving medicine, and this piece won't pretend otherwise.

The reason 4S worked is that those people's starting risk was high — more than one in ten died in five years. Thirty percent off a large risk is a large saving. But the relative headline stays about the same even when your real risk is tiny — and then the same "30%" means almost nothing. This is pure How Risk Is Sold. Watch the same drug meet two people:

Same drug, near-identical headline — but the absolute benefit is about three times larger for the person already sick, purely because they had more risk to lose. For the healthy person, a pill sold as cutting risk by a third shifts their real chance by about one in a hundred.

And here's the mechanism.

Let's be blunt, because many people have been told their symptoms are imaginary: statin side effects are real. Muscle pain, weakness, fatigue — and if you've watched someone become a shadow of themselves on a statin, you weren't imagining it. The mechanism follows directly from the production line.

Remember CoQ10. It's made on the same line the statin shuts down, and your mitochondria — the engines that power every cell — need it to make energy. When the statin turns the line down, CoQ10 falls with the cholesterol. This depletion has been measured in human blood and muscle; it isn't theoretical.[3]

Now look at where it lands. The tissues most dependent on constant energy — muscle, heart, brain — are exactly the ones most vulnerable to a CoQ10 drop, and exactly where the side effects appear. The pattern of the harm matches the mechanism.

You can answer this yourself now. If the cholesterol is high because the fire is burning — high insulin, SREBP switched on — then addressing the cause doesn't mean forcing the number down from outside. It means putting out the fire.

And watch what happens when you do. Turn off the flood, insulin falls, SREBP quiets, and the liver makes less cholesterol of its own accord — no drug fighting it. But that's the least of it. Because you addressed the root rather than one branch, the whole picture improves at once:

• The cholesterol pattern shifts (triglycerides down, HDL up, the particle mix toward the harmless kind),
• the blood sugar settles, the blood pressure eases, the fatty liver recedes, the inflammation cools —
• because these were never separate problems. They were all the one fire, and you turned it down.

Here's the quiet proof, worth sitting with. When your doctor manages your cholesterol, what do they measure? Your LDL cholesterol. They do not measure your fasting insulin. They do not measure the inflammation. They're chasing the one reading they happen to take — a downstream marker — while the fire that drives it is never put on the chart at all. You can have a "well-controlled" cholesterol number on a statin while the fire underneath burns exactly as hot as before.

Named clearly.

There's a group for whom this whole framing genuinely doesn't apply. Some people are born with familial hypercholesterolemia (FH), a genetic condition in which the body can't clear LDL properly and cholesterol runs enormously high from birth — independent of any fire.

For them, cholesterol really is the disease. The fuel load is so vast that even a cool, healthy terrain can't compensate, and they suffer heart attacks tragically young. For these people, statins and stronger cholesterol-lowering drugs are genuinely life-saving, and lowering the number is exactly the right target.